Articles about 'Chris Abell'

10 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.    

The University is saddened to announce that Professor Chris Abell, Pro-Vice-Chancellor for Research, Professor of Biological Chemistry and Todd-Hamied Fellow of Christ’s College, has died suddenly at the age of 62.

In April 2020, the University of Cambridge joined forces with AstraZeneca and GSK to create the Cambridge Testing Centre to boost the UK’s COVID-19 testing capabilities through innovation and cutting-edge technology.

The University of Cambridge and Cambridge University Press announced on 8 July 2019 that they have signed up to the San Francisco Declaration on Research Assessment (DORA), a set of recommendations agreed in 2012 that seek to ensure that the quality and impact of research outputs are 'measured accurately and evaluated wisely'.

The University of Cambridge has been presented with a Leader in Openness Award in recognition of its work to promote openness and transparency around its research involving the use of animals.

Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.

The Cambridge Academy of Therapeutic Sciences (CATS) has been awarded £1million over two years by Wellcome as a part of a new scheme to find new ways to translate scientific discoveries into real world impact.

Funding approved for research projects involving UC Berkeley, Cambridge and the National University of Singapore

Artificial intelligence has the power to eradicate poverty and disease or hasten the end of human civilisation as we know it – according to a speech delivered by Professor Stephen Hawking this evening.

A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers at the University of Cambridge. The findings are published Friday (10 February) in the journal Science.